Diabetes and endocrine clinical service guidance published during COVID-19
Guidance about what diabetes and endocrine clinical services can provide during the continue COVID-19 disruption and reduced capacity for clinical teams has been issued.
The document, Delivering Diabetes and Endocrine Services in Acute NHS Trusts during COVID-19 Pandemic reset, was formulated by ABCD.
ABCD has worked closely with the Society for Endocrinology (SfE) and RCP London and produced the guidance in response to NHS England seeking information about what services can currently be provided in the wake of reduced clinical capacity due to Coronavirus Pandemic.
Dr Dinesh Nagi, Consultant Physician with interests in diabetes & endocrinology at the Mid Yorkshire NHS Trust and immediate past ABCD Chair, said: “From the intelligence gathered, it is clear that the impact of disruption on clinical services during COVID-19 pandemic has been varied depending upon the size of the clinical teams.
“We hope that the guidance will provide some useful framework for the clinical team leaders and managers in the face of any further disruption of clinical services.”
To access the guidance, click here.